Viewing Study NCT06767956

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:33 PM
Ignite Modification Date: 2026-02-17 @ 10:12 PM
Study NCT ID: NCT06767956
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-06-04
First Post: 2025-01-05
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Golcadomide and Nivolumab in Patients With Non-Hodgkin Lymphoma With Refractory Disease After Chimeric Antigen T-cell Therapy
Sponsor: Natalie Galanina
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Non Hodgkin Lymphoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None refractory disease View
None chimeric antigen View
None B cell lymphomas View
None Cereblon E3 Ligase Modulators (CELMoD) View
None immunomodulatory drugs (IMiD) View
None tumor microenvironment (TME) View